Dr. Nicholas Franich
Preclinical trials in Huntington's disease mouse models
Dr. Franich received his PhD in Molecular Medicine from the University of Auckland, New Zealand, for work on recombinant AAV vector-mediated gene transfer for modeling Huntington's disease and evaluating gene therapy strategies. In 2009, he joined the laboratory of Dr. Marie-Francoise Chesselet, in the Department of Neurology at UCLA, as a Postdoctoral Scholar. His current research focuses on genetic mouse models of Huntington's disease and Parkinson's disease, in both basic research and preclinical trials, including investigating antisense oligonucleotide therapeutics, in collaboration with and supported by ISIS Pharmaceuticals, Hereditary Disease Foundation and CHDI.